Smart ring maker Oura to acquire Counsel Health for $625 million

Smart-ring manufacturer Oura has agreed to acquire Counsel Health, an AI-native primary-care company, for $625 million according to simultaneous reports from the Wall Street Journal, Reuters, Bloomberg, TechCrunch and The Business Journals. The transaction marks Oura's largest acquisition to date and signals a strategic pivot from consumer wearables into clinical care delivery.

All five outlets emphasize the AI-native description of Counsel Health, suggesting the startup has built its care model around large-language-model-driven triage, documentation and clinical decision support rather than bolting AI onto an existing practice. Bloomberg adds that Oura posted a 153 percent sales jump, though the period covered is not specified in the headlines. The Business Journals and TechCrunch both highlight that Oura delayed its previously planned initial public offering, framing the acquisition as an alternative capital-deployment strategy while the IPO window remains uncertain. Reuters and the Wall Street Journal note the deal is expected to close subject to customary regulatory approvals, without providing a target timeline.

Context for the move includes Oura's evolution from a sleep-tracking ring into a broader health platform that now offers heart-rate variability, temperature trends and women's health features. By integrating Counsel Health's clinical infrastructure, Oura could move from data collection to diagnosis and prescription, entering a regulated space currently dominated by Teladoc, Amwell and health-system-owned virtual clinics. The acquisition also reflects a wider trend of consumer-health hardware firms buying clinical capabilities—following patterns set by Fitbit's acquisition of Twine Health and Amazon's purchase of One Medical—but at a valuation that suggests investors are pricing in rapid revenue synergies rather than user growth alone.

What to watch next includes regulatory scrutiny of an AI-first care model, particularly around licensure, liability and reimbursement codes for algorithmically guided visits. Coverage does not yet specify whether Counsel Health's clinicians will remain independent or become Oura employees, nor does it detail how the combined entity will handle data sharing between the ring's continuous biometrics and the clinical record. Analysts cited by Bloomberg suggest the deal could accelerate Oura's path to profitability if payer contracts materialize, but the headlines provide no guidance on projected revenue contribution or integration milestones.